Benaroya Research Institute at Virginia Mason | Clinical Trials Unit

Research site

(Unclaimed)

Location

1100 9th Avenue, Seattle, Washington, United States of America

Site insights

Top conditions

Top treatments

CTS-1027

Obatoclax

Gemcitabine

Luspatercept

RPC1063

Methoxsalen

BHT-3021

Tamoxifen

Enfortumab

Atezolizumab

Parent organization

This site is a part of Benaroya Research Institute at Virginia Mason

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 35 total trials

A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer

This is a multi-site, open-label, Phase II, randomized, trial to compare the efficacy of RO7198457 versus watchful waiting in patients with circulati...

Enrolling

Colorectal Cancer Stage III

Colorectal Cancer Stage II

Drug: RO7198457 intravenous (IV)

Other: Observational group (no intervention)

A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Patients With Unresectable Hepatocellular Carcinoma and Child-Pugh B7 and B8 Cirrhosis (Kirros)

The purpose of this study is to assess the safety and efficacy of atezolizumab and bevacizumab, or atezolizumab alone, as first-line treatment in par...

Enrolling

Hepatocellular Carcinoma

Drug: Atezolizumab

Drug: Bevacizumab

A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)

The purpose of this study was to compare the overall survival (OS) of participants with locally advanced or metastatic urothelial cancer treated with...

Active, not recruiting

Bladder Cancer

Urothelial Cancer

Drug: Enfortumab Vedotin

Drug: Vinflunine

Evaluate REC-4881 in Patients With FAP (TUPELO)

This is a multicenter, two-part trial in participants with Familial Adenomatous Polyposis (FAP).

Enrolling

Familial Adenomatous Polyposis

Drug: Placebo

Drug: REC-4881

FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)

This is a randomized, parallel group, double-blind Phase 2 study with a 52-week blinded extension evaluating the safety and efficacy of 3 dose levels...

Enrolling

Type 1 Diabetes Mellitus

Drug: Placebo

Drug: Insulin

Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer

This phase II trial studies how well gemcitabine, cisplatin, and nab-paclitaxel work before surgery in treating participants with high-risk bile duct...

Active, not recruiting

Stage II Intrahepatic Cholangiocarcinoma AJCC v8

Stage IB Intrahepatic Cholangiocarcinoma AJCC v8

Drug: Gemcitabine

Drug: Cisplatin

Study of Enhanced Programming Stimulation with the Enterra® Therapy System (EXPEDITE)

The purpose of this research study is to evaluate if an enhanced Enterra device programming strategy will improve symptoms associated with gastropare...

Enrolling

Gastroparesis

Gastroparesis Due to Diabetes Mellitus

Device: Enterra Therapy System